References
- US Food and Drug AdministrationEarly communication about an ongoing safety review of montelukast (Singulair), 2009 Postmarket drug safety information for patients and providers. Available at: http://www.fda.gov/drugs/drugsafety/postmarketdrugsafetyinformationforpatientsandproviders/drugsafetyinformationforhealthcareprofessionals/ucm070618.htm. Accessed June 24, 2011.
- US Food and Drug AdministrationUpdated information on leukotriene inhibitors: Montelukast (marketed as Singulair), zafirlukast (marketed as Accolate), and zileuton (marketed as Zyflo and Zyflo CR), 2009 Post-market drug safety information for patients and providers. Available at: http://www.fda.gov/drugs/drugsafety/postmarketdrugsafetyinformationforpatientsandproviders/drugsafetyinformationforhealthcareprofessionals/ucm165489.htm. Accessed June 24, 2011.
- US Food and Drug AdministrationFollow-up to the March 27, 2008 communication about the ongoing safety review of montelukast (Singulair), 2009 Postmarket drug safety information for patients and providers. Available at: http://www.fda.gov/drugs/drugsafety/postmarketdrugsafetyinformationforpatientsandproviders/drugsafetyinformationforhealthcareprofessionals/ucm079523.htm. Accessed June 24, 2011.
- BisgaardHSkonerDBozaMLSafety and tolerability of montelukast in placebo-controlled pediatric studies and their open-label extensionsPediatr Pulmonol200944656857919449366
- PhilipGHustadCNoonanGReports of suicidality in clinical trials of montelukastJ Allergy Clin Immunol2009124469169619815114
- PhilipGHustadCMMaliceMPAnalysis of behavior-related adverse experiences in clinical trials of montelukastJ Allergy Clin Immunol2009124469970619815116
- [No authors listed].Joint statement on FDA investigation of Singulair from the ACAAI and AAAAIEur Ann Allergy Clin Immunol200840264
- SchumockGTLeeTAJooMJValuckRJStaynerLTGibbonsRDAssociation between leukotriene-modifying agents and suicide: What is the evidence?Drug Saf201134753354421663330
- GibbonsRDHurKBhaumikDKMannJJThe relationship between antidepressant medication use and rate of suicideArch Gen Psychiatry200562216517215699293
- GibbonsRDHurKBhaumikDKMannJJThe relationship between antidepressant prescription rates and rate of early adolescent suicideAm J Psychiatry2006163111898190417074941
- National Center for Health StatisticsCompressed Mortality File, 1999–2006Hyattsville, MDNational Center for Health Statistics2009
- GoodwinRDOlfsonMSheaSAsthma and mental disorders in primary careGen Hosp Psychiatry200325647948314706414
- GoodwinRDMarusicAAsthma and suicidal ideation among youth in the communityCrisis20042539910215387235
- GoodwinRDEatonWWAsthma, suicidal ideation, and suicide attempts: Findings from the Baltimore epidemiologic catchment area follow-upAm J Public Health200595471772215798135
- DrussBPincusHSuicidal ideation and suicide attempts in general medical illnessesArch Intern Med2000160101522152610826468
- HarwoodDMHawtonKHopeTHarrissLJacobyRLife problems and physical illness as risk factors for suicide in older people: A descriptive and case-control studyPsychol Med20063691265127416734947
- TimonenMViiloKHakkoHIs seasonality of suicides stronger in victims with hospital-treated atopic disorders?Psychiatry Res2004126216717515123396
- MassingWAngermeyerMCThe monthly and weekly distribution of suicideSoc Sci Med19852144334414049013
- ChewKSMcClearyRThe spring peak in suicides: A cross-national analysisSoc Sci Med19954022232307899934
- PostolacheTTStillerJWHerrellRTree pollen peaks are associated with increased nonviolent suicide in womenMol Psychiatry200510323223515599378
- PostolacheTTKomarowHTonelliLHAllergy: A risk factor for suicide?Curr Treat Options Neurol200810536337618782509
- GoodwinRDCastroMKovacsMMajor depression and allergy: Does neuroticism explain the relationship?Psychosom Med2006681949816449417
- TimonenMJokelainenJHervaAZittingPMeyer-RochowVBRasanenPPresence of atopy in first-degree relatives as a predictor of a female proband’s depression: Results from the northern Finland 1966 birth cohortJ Allergy Clin Immunol200311161249125412789225
- TimonenMJokelainenJHakkoHAtopy and depression: Results from the Northern Finland 1966 birth cohort studyMol Psychiatry20038873874412888802
- TimonenMJokelainenJSilvennoinen-KassinenSAssociation between skin test diagnosed atopy and professionally diagnosed depression: A Northern Finland 1966 birth cohort studyBiol Psychiatry200252434935512208642
- RosenbergHImproving cause-of-death statisticsAm J Public Health19897955635642705587
- MoyerLABoyleCAPollockDAValidity of death certificates for injury-related causes of deathAm J Epidemiol19891305102410322683747
- AndradeSEKahlerKHFrechFChanKAMethods for evaluation of medication adherence and persistence using automated databasesPharmacoepidemiol Drug Saf200615856557416514590
- LauHSDe BoerABeuningKSPorsiusAValidation of pharmacy records in drug exposure assessmentJ Clin Epidemiol19975056196259180655